DAVINA PHARMACY LIMITED

DAVINA PHARMACY LIMITED

DAVINA PHARMACY LIMITED - Company Information

Print Friendly Version

DAVINA PHARMACY LIMITED

Company Registration Number:
04990110 (England and Wales)

Unaudited abridged accounts for the year ended 31 July 2017

Period of accounts

Start date: 01 August 2016

End date: 31 July 2017

DAVINA PHARMACY LIMITED

Contents of the Financial Statements

for the Period Ended 31 July 2017

Balance sheet
Notes

DAVINA PHARMACY LIMITED

Balance sheet

As at 31 July 2017


Notes
2017
2016


£
£
Fixed assets
Intangible assets: 3 192,000 208,000
Tangible assets: 4 90,569 116,214
Total fixed assets: 282,569 324,214
Current assets
Stocks: 34,869 51,853
Debtors:   206,514 195,188
Cash at bank and in hand: 22,858 18,912
Total current assets: 264,241 265,953
Creditors: amounts falling due within one year:   (291,040) (331,387)
Net current assets (liabilities): (26,799) (65,434)
Total assets less current liabilities: 255,770 258,780
Total net assets (liabilities): 255,770 258,780
Capital and reserves
Called up share capital: 100 100
Profit and loss account: 255,670 258,680
Shareholders funds: 255,770 258,780

The notes form part of these financial statements

DAVINA PHARMACY LIMITED

Balance sheet statements

For the year ending 31 July 2017 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

The members have agreed to the preparation of abridged accounts for this accounting period in accordance with Section 444(2A).

These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

The directors have chosen to not file a copy of the company’s profit & loss account.

This report was approved by the board of directors on 06 February 2018
and signed on behalf of the board by:

Name: A N Mehta
Status: Director

The notes form part of these financial statements

DAVINA PHARMACY LIMITED

Notes to the Financial Statements

for the Period Ended 31 July 2017

1. Accounting policies

These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

Turnover policy

Turnover is measured at the fair value of the consideration received or receivable, excluding value added tax.

Tangible fixed assets and depreciation policy

Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life -Property refurbishment - 20% on reducing balancePlant and machinery - 25% on reducing balanceFixtures and fittings - 25% on reducing balanceComputer equipment - 25% on reducing balance

Intangible fixed assets and amortisation policy

Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

Other accounting policies

StocksStocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.TaxationTaxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it related to items recognised in other comprehensive income or directly in equity.Hire purchase and leasing commitmentsRentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.Pension costs and other post-retirement benefitsThe company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

DAVINA PHARMACY LIMITED

Notes to the Financial Statements

for the Period Ended 31 July 2017

2. Employees

2017 2016
Average number of employees during the period 14 17

DAVINA PHARMACY LIMITED

Notes to the Financial Statements

for the Period Ended 31 July 2017

3. Intangible Assets

Total
Cost £
At 01 August 2016 400,000
At 31 July 2017 400,000
Amortisation
At 01 August 2016 192,000
Charge for year 16,000
At 31 July 2017 208,000
Net book value
At 31 July 2017 192,000
At 31 July 2016 208,000

DAVINA PHARMACY LIMITED

Notes to the Financial Statements

for the Period Ended 31 July 2017

4. Tangible Assets

Total
Cost £
At 01 August 2016 283,843
At 31 July 2017 283,843
Depreciation
At 01 August 2016 167,629
Charge for year 25,645
At 31 July 2017 193,274
Net book value
At 31 July 2017 90,569
At 31 July 2016 116,214

DAVINA PHARMACY LIMITED

Notes to the Financial Statements

for the Period Ended 31 July 2017

5. Related party transactions

Included in creditors is an amount of £37,424 (2016 £49,289) owed to the director. The loan is unsecured, interest free and repayable on demand.